Studies on pyridonecarboxylic acids. IV. Synthesis and antibacterial activity evaluation of S-(-)- and R-(+)-6-fluoro-1-methyl-4-oxo-7- (1-piperazinyl)-4H-[1,3] thiazeto[3,2-a]quinoline-3-carboxylic acids. 1995

J Segawa, and K Kazuno, and M Matsuoka, and I Amimoto, and M Ozaki, and M Matsuda, and Y Tomii, and M Kitano, and M Kise
Chemistry Laboratory, Nippon Shinyaku Company, Ltd., Kyoto, Japan.

Optically active isomers of 6-fluoro-1-methyl-4-oxo-7-(1-piperazinyl)-4H- [1,3] thiazeto [3,2-alpha] quinoline-3- carboxylic acid (NM394, 3) were prepared through optical resolution of their racemic intermediate ( +/- )-1 by high-performance liquid chromatography (HPLC). The absolute configuration at the C-1 position in the thiazeto-quinolone ring of ( - )-3 was confirmed by X-ray analysis ( - )-4 to be S. The in vitro antibacterial activity of ( - )-3 was 2--8 times that of (+)-3.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D004926 Escherichia coli A species of gram-negative, facultatively anaerobic, rod-shaped bacteria (GRAM-NEGATIVE FACULTATIVELY ANAEROBIC RODS) commonly found in the lower part of the intestine of warm-blooded animals. It is usually nonpathogenic, but some strains are known to produce DIARRHEA and pyogenic infections. Pathogenic strains (virotypes) are classified by their specific pathogenic mechanisms such as toxins (ENTEROTOXIGENIC ESCHERICHIA COLI), etc. Alkalescens-Dispar Group,Bacillus coli,Bacterium coli,Bacterium coli commune,Diffusely Adherent Escherichia coli,E coli,EAggEC,Enteroaggregative Escherichia coli,Enterococcus coli,Diffusely Adherent E. coli,Enteroaggregative E. coli,Enteroinvasive E. coli,Enteroinvasive Escherichia coli
D000890 Anti-Infective Agents Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. Anti-Infective Agent,Anti-Microbial Agent,Antimicrobial Agent,Microbicide,Microbicides,Anti-Microbial Agents,Antiinfective Agents,Antimicrobial Agents,Agent, Anti-Infective,Agent, Anti-Microbial,Agent, Antimicrobial,Agents, Anti-Infective,Agents, Anti-Microbial,Agents, Antiinfective,Agents, Antimicrobial,Anti Infective Agent,Anti Infective Agents,Anti Microbial Agent,Anti Microbial Agents
D001412 Bacillus subtilis A species of gram-positive bacteria that is a common soil and water saprophyte. Natto Bacteria,Bacillus subtilis (natto),Bacillus subtilis subsp. natto,Bacillus subtilis var. natto
D013211 Staphylococcus aureus Potentially pathogenic bacteria found in nasal membranes, skin, hair follicles, and perineum of warm-blooded animals. They may cause a wide range of infections and intoxications.
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015363 Quinolones A group of derivatives of naphthyridine carboxylic acid, quinoline carboxylic acid, or NALIDIXIC ACID. Ketoquinoline,Ketoquinolines,Oxoquinoline,Oxoquinolines,Quinolinone,Quinolinones,Quinolone

Related Publications

J Segawa, and K Kazuno, and M Matsuoka, and I Amimoto, and M Ozaki, and M Matsuda, and Y Tomii, and M Kitano, and M Kise
April 2008, International journal of antimicrobial agents,
J Segawa, and K Kazuno, and M Matsuoka, and I Amimoto, and M Ozaki, and M Matsuda, and Y Tomii, and M Kitano, and M Kise
May 1987, Yao xue xue bao = Acta pharmaceutica Sinica,
J Segawa, and K Kazuno, and M Matsuoka, and I Amimoto, and M Ozaki, and M Matsuda, and Y Tomii, and M Kitano, and M Kise
December 1999, Chemical & pharmaceutical bulletin,
J Segawa, and K Kazuno, and M Matsuoka, and I Amimoto, and M Ozaki, and M Matsuda, and Y Tomii, and M Kitano, and M Kise
November 1997, Yao xue xue bao = Acta pharmaceutica Sinica,
J Segawa, and K Kazuno, and M Matsuoka, and I Amimoto, and M Ozaki, and M Matsuda, and Y Tomii, and M Kitano, and M Kise
January 1991, Yao xue xue bao = Acta pharmaceutica Sinica,
J Segawa, and K Kazuno, and M Matsuoka, and I Amimoto, and M Ozaki, and M Matsuda, and Y Tomii, and M Kitano, and M Kise
January 1989, Yao xue xue bao = Acta pharmaceutica Sinica,
J Segawa, and K Kazuno, and M Matsuoka, and I Amimoto, and M Ozaki, and M Matsuda, and Y Tomii, and M Kitano, and M Kise
September 1986, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
J Segawa, and K Kazuno, and M Matsuoka, and I Amimoto, and M Ozaki, and M Matsuda, and Y Tomii, and M Kitano, and M Kise
September 1987, Journal of medicinal chemistry,
J Segawa, and K Kazuno, and M Matsuoka, and I Amimoto, and M Ozaki, and M Matsuda, and Y Tomii, and M Kitano, and M Kise
September 1998, Yao xue xue bao = Acta pharmaceutica Sinica,
J Segawa, and K Kazuno, and M Matsuoka, and I Amimoto, and M Ozaki, and M Matsuda, and Y Tomii, and M Kitano, and M Kise
September 1986, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Copied contents to your clipboard!